NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

吸引針·切片穿刺針的全球市場 (2020年∼2027年)

Global Aspiration and Biopsy Needles Market - 2020-2027

出版商 DataM Intelligence 商品編碼 1008531
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
吸引針·切片穿刺針的全球市場 (2020年∼2027年) Global Aspiration and Biopsy Needles Market - 2020-2027
出版日期: 2021年06月01日內容資訊: 英文 180 Pages
簡介

吸引針和活檢針在世界範圍內的主要市場推動因素是各種癌症發病率的增加、各國政府的啟蒙活動以及社會利益的擴大。乳腺活檢應用佔比最大,醫院終端用戶佔比最大。按地區劃分,亞太地區是最大的市場。

本報告提供全球吸引針·切片穿刺針的市場相關分析,提供市場規模趨勢預測,及各產品種類·各用途·治療·各終端用戶·各地區的詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等相關調查。

目錄

第1章 全球吸引針·切片穿刺針市場:分析方法·範圍

第2章 全球吸引針·切片穿刺針市場:市場定義和概要

第3章 全球吸引針·切片穿刺針市場:摘要整理

第4章 全球吸引針·切片穿刺針市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球吸引針·切片穿刺針市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球吸引針·切片穿刺針市場:新型冠狀病毒感染疾病 (COVID-19)的分析

  • COVID-19對市場的影響分析
    • COVID-19前的市場方案
    • 目前市場方案
    • COVID-19後的市場方案
  • COVID-19疫情下的價格趨勢
  • 需求與供給的變動階段
  • 政府在COVID-19疫情下的市場相關措施
  • 各製造公司的策略展開情形
  • 結論

第7章 全球吸引針·切片穿刺針市場:各產品種類

  • 簡介
  • 市場規模的分析與與前一年同期相比成長率 (YoY):各產品種類
  • 市場向心力指數:各產品種類
  • 粗針切片
    • 簡介
    • 市場規模·與前一年同期相比成長率 (YoY)
  • 細微針

第8章 全球吸引針·切片穿刺針市場:各用途

  • 簡介
  • 市場規模的分析與與前一年同期相比成長率 (YoY):各用途
  • 市場向心力指數:各用途
  • 乳房切片
  • 肺切片檢查
  • 前列腺切片檢查
  • 骨·骨髓切片檢查

第9章 全球吸引針·切片穿刺針市場:各治療

  • 簡介
  • 市場規模的分析與與前一年同期相比成長率 (YoY):各治療
  • 市場向心力指數:各治療
  • 影像誘導治療
  • 非影像誘導治療
  • 其他

第10章 全球吸引針·切片穿刺針市場:各終端用戶

  • 簡介
  • 市場規模的分析與與前一年同期相比成長率 (YoY):各終端用戶
  • 市場向心力指數:各終端用戶
  • 醫院
  • 診斷中心
  • 研究機關
  • 診所

第11章 全球吸引針·切片穿刺針市場:各地區

  • 簡介
  • 市場規模和與前一年同期相比成長率 (YoY):各地區
  • 市場向心力指數:各地區
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模·與前一年同期相比成長率 (YoY):各產品種類
    • 市場規模·與前一年同期相比成長率 (YoY):各用途
    • 市場規模·與前一年同期相比成長率 (YoY):各治療
    • 市場規模·與前一年同期相比成長率 (YoY):各終端用戶
    • 市場規模·與前一年同期相比成長率 (YoY):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第12章 全球吸引針·切片穿刺針市場:競爭情形

  • 競爭方案
  • 市場定位/佔有率分析
  • 企業合併·收購 (M&A)的分析

第13章 全球吸引針·切片穿刺針市場:企業簡介

  • Olympus Corporation
    • 企業概要
    • 產品的組合/概要
    • 近幾年趨勢
    • 財務分析:概要
  • Boston Scientific Corporation
  • Medtronic plc
  • Stryker Corporation
  • Becton
  • Dickinson and Company
  • Argon Medical Devices, Inc.
  • CONMED Corporation
  • Merit Medical Systems, Inc.
  • Sterylab s.r.l.

第14章 全球吸引針·切片穿刺針市場:重要考察

第15章 關於DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

The global aspiration and biopsy needles market size was worth US$ XX billion in 2018 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).

Fine needle aspiration is a type of procedure for biopsy. A thin needle is inserted into the area of abnormal-appearing tissue or body fluid during fine needle aspiration. As with other types of biopsies, the sample collected from body fluid or abnormal tissue during the fine needle aspiration can help diagnose or rule out cancer conditions. Fine needle aspiration is usually considered a safe procedure. Standard needle biopsy procedures include fine-needle aspiration and core needle biopsy.

  • Fine-needle aspiration. This type of needle biopsy uses a thin, hollow needle to extract cells from the body.
  • Core needle biopsy. It uses a wider needle, a hollow tube that allows the extraction of a tissue sample for testing.

Needle biopsy has a small risk of bleeding and infection at the site where the needle was inserted. Some mild pain can be expected after a needle biopsy, though it is usually controlled with over-the-counter pain relievers.

Market Dynamics

The growth in global aspiration and biopsy needles market is driven by the growing incidence of various cancer cases, initiative programs undertaking by the government to improve clinical awareness among the common people are among the key factors growing the market growth.

Increasing prevalence of various cancers, is expected to drive the growth in the forecast period

The growing incidence of cancer is the most crucial factor driving the growth of the aspiration and biopsy needles market. According to the World Health Organization (WHO), in 2030, 21.4 million new patients will be diagnosed with malignant tumors, compared to 12.7 million in 2008. Also, cancer accounted for 9.6 million deaths across the globe in 2018. Looking at the growth in the cancer cases reported every year, the government and health ministries are stepping forward to invest more in medical equipment.

Initiative programs undertaking by the government to improve clinical awareness among the common people

By Indian Cancer Society: Cancer Awareness Campaign 2019: The campaign is called "Raho cancer se do Kadam aage,"aims to create cancer awareness amongst the population of India. It is essential to destroy the myths that people wrongly believe, inform them about the signs and symptoms and the importance of screening for early detection. It is also essential to follow a healthy lifestyle, and sharing survivor stories give hope and confidence.

National Comprehensive Cancer Control Program: More than 98,000 people have been involved in cancer coalitions, and Sixty-nine cancer plans have been created and updated.

National Breast and Cervical Cancer Early Detection Program (NBCCEDP): Through the NBCCEDP, CDC helping low-income, uninsured, and underinsured women to gain access to frequent breast and cervical cancer screening, diagnostic, and treatment services. . During 2016-2017, about 5.3% of U.S. women were eligible for this program, breast cancer screening services, and the program served 15.0% of qualified women.

High cost of treatment in low- income countries is likely to hinder the market growth

With low-income countries providing only 20% of health insurance reimbursements, it is becoming difficult for people to afford the bills and opt for minimally invasive surgeries. For instance, As per the National Library of Medicine, the Procedure-related costs were $368.5 and $981.0 for fine-needle aspiration biopsy and core-needle biopsy in the treatment of cell carcinoma.

COVID-19 Impact Analysis

Due to the covid-19 pandemic outbreak, the market was down due to the barriers in production and sale segments. Since the outbreak led to all manufacturing firms' shutdown except for masks, sanitizers and ventilators, the products were manufactured less compared to the previous year.

Segment Analysis

Based on the Product Type, the global aspiration and biopsy needle market is segmented into core-needle biopsy and fine-needle biopsy.

Based on the type of products, there are two types of needles used for biopsy purpose. One being core needles and other being fine needles. Core needles are expected to experience a higher CAGR in the market for aspiration and biopsy needles during the forecast period. More tissue can be extracted by a core needle biopsy than by a fine needle biopsy. As per the National Library of Medicine, in determining the exact diagnosis, fine-needle aspiration had a 33.3% accuracy, and core biopsy had a 45.6% accuracy. Concerning eventual treatment, fine-needle aspiration was 38.6% accurate, and core biopsy was 49.1% accurate. In soft tissue mass diagnosis, core biopsy is more precise than fine-needle aspiration. As a result, more information about the cells and tissue extracted can be given.

Based on application, the global aspiration and biopsy needle market is segmented into breast biopsy, lung biopsy, prostate biopsy, bone marrow biopsy.

The highest revenue-generating segment on the market for aspiration and biopsy needles, based on application, will be breast biopsy before 2030. According to the Institute for Health Measurements and Evaluation (IHME), due to the increasing prevalence of breast cancer, 2017 killed 611,625 women, compared to 600,762 in 2016.

Based on procedure, the global aspiration and biopsy needle market is segmented into image-guided procedures and non-image guided procedures.

Based on Procedure, the global Aspiration and Biopsy Needles market is segmented into image-guided procedures (Ultrasound-guided, Stereotactic-guided, Magnetic Resonance Imaging MRI-guided, and Other image-guided procedures) and Non-image-guided procedures. Image Guided procedure is highly preferred by surgeons, reason being that image guided procedure has minimum chances of diagnosis errors by accurately locating the mass of cells and liquid.

Based on end user, the global aspiration and biopsy needle market is segmented into hospitals, diagnostic and imaging centers, research institutes.

As an end-user, hospitals held the largest market share during the historical period (2014-2019), and the situation in the coming years is projected to be the same. This is because hospitals serve a far larger number of patients relative to diagnostic centers and clinics and developing healthcare infrastructure in emerging nations.

Geographical Analysis

Asia - Pacific region holds the largest market share in global aspiration and biopsy needles market

Asia- Pacific holds the largest share in the market. The reason can be attributed to the fact that the leading Olympus company which is a Japanese based company holds around 70% of the endoscope market. It is reported by CDC that, Australia is leading country with 468 cases of cancer per 100,000 population. Followed by New Zealand and Ireland. The reason can be attributed to fast growing industrialization and growing consumption of alcohol and drugs.

North America also expected to fast-growing market in the forecasting period owing to the increasing prevalence of cancer patients and its awareness programs undertaken by the local government and global health organisation in the region are the key factors of the market growth.

Competitive Landscape

The global aspiration and biopsy needles market is highly competitive with key layers like Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Becton, Stryker Corporation, Dickinson and Company, Argon Medical Devices, CONMED Corporation, Merit Medical Devices, Inc., Sterylab s.r.l. These companies adopted the strategy of product launch, acquisition and investments in major sectors and partnerships. For instance, Boston Scientific Corporation acquired 44 companies with Preventive Solutions being its recent acquisition.

In February 2018, the US-based Merit Medical Systems, Inc. announced the closure of its purchase of divestment assets from BD (Becton, Dickinson and Company).

Olympus Corporation

Company Overview: Olympus Corporation is a maker of optics and reprography products in Japan. On 12 October 1919, Olympus was founded, initially specializing in microscopes and thermometers. Olympus owns approximately 70 percent of the global endoscope market, which is estimated to be worth around US$2.5 billion.

Product Portfolio: The Company's portfolio comprised of manufactured products like TBNA Needles,

Reusable- Aspiration Biopsy Needles with side ports (NA-2C-1)

The needle is made of stainless-steel sheath which protects the biopsy channel during insertion and enables accurate positioning while side port allows larger cell collection.

Key developments:

On Sep 2018, Olympus announced clearance from FDA for its new innovation, EZ Shot 3 Plus 25 G EUS Needle with enhanced manoeuvrability. This product has predictability feature which can predict trajectory and echogenicity of EZ Shot 3 Plus line, offering an expanded indication for FNA and FBA.

Why Purchase the Report?

  • Visualize the composition of the global aspiration and biopsy needles market segmentation by product type, by application, by procedure, by end-users, by region.
  • Identify commercial opportunities in global aspiration and biopsy needles market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global aspiration and biopsy needles market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global aspiration and biopsy needles market report would provide an access to an approx. 69 market data table, 61 figures and 300 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Aspiration and Biopsy Needles Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Aspiration and Biopsy Needles Market - Market Definition and Overview

3. Global Aspiration and Biopsy Needles Market - Executive Summary

  • 3.1. Market Snippet by Product type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Procedure
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Global Inhalation Therapy Nebulizer Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of various cancer diseases
      • 4.1.1.2. Initiative programs undertaken by the government
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of treatment in low-income countries
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Aspiration and Biopsy Needles Market - Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis
  • 5.5 Reimbursement Analysis
  • 5.6 Unmet Needs

6. Global Aspiration and Biopsy Needles Market - COVID-19 Analysis

  • 6.1 Analysis of Covid-19 on the Market
    • 6.1.1 Before COVID-19 Market Scenario
    • 6.1.2 Present COVID-19 Market Scenario
    • 6.1.3 After COVID-19 or Future Scenario
  • 6.2 Pricing Dynamics Amid Covid-19
  • 6.3 Demand-Supply Spectrum
  • 6.4 Government Initiatives Related to the Market During Pandemic
  • 6.5 Manufacturers Strategic Initiatives
  • 6.6 Conclusion

7. Global Aspiration and Biopsy Needles Market - By Product Type

  • 7.1 Introduction
  • 7.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  • 7.3 Market Attractiveness Index, By Product Type
  • 7.4 Core needle*
    • 7.4.1 Introduction
    • 7.4.2 Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.5 Fine needle

8. Global Aspiration and Biopsy Needles Market - By Application

  • 8.1 Introduction
  • 8.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3 Market Attractiveness Index, By Application
  • 8.4 Breast Biopsy*
    • 8.4.1 Introduction
    • 8.4.2 Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 8.5 Lung Biopsy
  • 8.6 Prostate Biopsy
  • 8.7 Bone and Bone Marrow Biopsy

9. Global Aspiration and Biopsy Needles Market - By Procedure

  • 9.1 Introduction
  • 9.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
  • 9.3 Market Attractiveness Index, By Procedure
  • 9.4 Image Guided*
    • 9.4.1 Introduction
    • 9.4.2 Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 9.5 Non-Image Guided
  • 9.6 Others

10. Global Aspiration and Biopsy Needles Market - By End user

  • 10.1 Introduction
  • 10.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.3 Market Attractiveness Index, By End user
  • 10.4 Hospitals*
    • 10.4.1 Introduction
    • 10.4.2 Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 10.5 Diagnostic centres
  • 10.6 Research Institutes
  • 10.7 Clinics

11. Global Aspiration and Biopsy Needles Market - By Region

  • 11.1 Introduction
  • 11.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 11.3 Market Attractiveness Index, By Region
  • 11.4 North America
    • 11.4.1 Introduction
    • 11.4.2 Key Region-Specific Dynamics
    • 11.4.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.4.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1 U.S.
      • 11.4.7.2 Canada
      • 11.4.7.3 Mexico
  • 11.5 Europe
    • 11.5.1 Introduction
    • 11.5.2 Key Region-Specific Dynamics
    • 11.5.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.5.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1 Germany
      • 11.5.7.2 U.K.
      • 11.5.7.3 France
      • 11.5.7.4 Italy
      • 11.5.7.5 Spain
      • 11.5.7.6 Rest of Europe
  • 11.6 South America
    • 11.6.1 Introduction
    • 11.6.2 Key Region-Specific Dynamics
    • 11.6.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.6.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.6.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.6.7.1 Brazil
      • 11.6.7.2 Argentina
      • 11.6.7.3 Rest of South America
  • 11.7 Asia Pacific
    • 11.7.1 Introduction
    • 11.7.2 Key Region-Specific Dynamics
    • 11.7.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.7.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.7.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.7.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.7.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.7.7.1 China
      • 11.7.7.2 India
      • 11.7.7.3 Japan
      • 11.7.7.4 Australia
      • 11.7.7.5 Rest of Asia Pacific
  • 11.8 Middle East and Africa
    • 11.8.1 Introduction
    • 11.8.2 Key Region-Specific Dynamics
    • 11.8.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.8.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.8.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.8.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

12. Global Aspiration and Biopsy Needles Market - Competitive Landscape

  • 12.1 Competitive Scenario
  • 12.2 Market Positioning/Share Analysis
  • 12.3 Mergers and Acquisitions Analysis

13. Global Aspiration and Biopsy Needles Market- Company Profiles

  • 13.1 Olympus Corporation*
    • 13.1.1 Company Overview
    • 13.1.2 Product Portfolio and Description
    • 13.1.3 Key Highlights
    • 13.1.4 Financial Overview
  • 13.2 Boston Scientific Corporation
  • 13.3 Medtronic plc
  • 13.4 Stryker Corporation
  • 13.5 Becton
  • 13.6 Dickinson and Company
  • 13.7 Argon Medical Devices, Inc.
  • 13.8 CONMED Corporation
  • 13.9 Merit Medical Systems, Inc.
  • 13.10 Sterylab s.r.l.

LIST NOT EXHAUSTIVE

14. Global Aspiration and Biopsy Needles Market - Premium Insights

15. Global Aspiration and Biopsy Needles Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us